Healthcare

What Pharma Manufacturers Need to Know about Consumer Drug Take-Back

As jurisdictions across the U.S. continue implementing and enforcing disparate legislation mandating drug take-back programs, the burden of funding and execution for these programs has fallen upon pharmaceutical manufacturers. 

• Read more about What Pharma Manufacturers Need to Know about Consumer Drug Take-Back

Inmar Intelligence To Host Drive-Thru Consumer Drug Take Back Event at Its Winston-Salem Headquarters on Saturday, April 24, 2021

In support of the DEA’s National Prescription Drug Take Back Day on April 24, Inmar Intelligence, a data-driven technology-enabled services company, will host its second consumer drug take back event in conjunction with the DEA, the State Bureau of Investigation and the Winston-Salem Police Department. The date is also Inmar’s 41st company anniversary.

• Read more about Inmar Intelligence To Host Drive-Thru Consumer Drug Take Back Event at Its Winston-Salem Headquarters on Saturday, April 24, 2021

Rx Audit Management: A Tool for the Times

Payers and PBMs have demonstrated much needed flexibility during the Covid-19 pandemic and their willingness to accommodate pharmacies has enabled providers to successfully contend with any number of business and operational challenges. However, as progress against the pandemic continues to accelerate and focus returns to more “normal” business activity, the likelihood of increased pharmacy audits is growing.

• Read more about Rx Audit Management: A Tool for the Times

How Your Facility Can Harness AI to Get Ahead of Drug Diversion

Clinical drug diversion is a critical issue in pharmacies and health systems nationwide. Healthcare workers who steal or misuse controlled substances (CS) cause direct harm to patients and put their employers at risk for financial penalties and sanctions.   Presented by Dwight de Vera, GM Healthcare Intelligence at Inmar, and Nick Culbertson, Co-Founder and CEO at Protenus, this webinar explores the following:

• Read more about How Your Facility Can Harness AI to Get Ahead of Drug Diversion

Accelerating Healthcare: Drug Diversion Surveillance

While the Covid-19 pandemic continues to dominate the news, coverage of America’s “other” health crisis -- the opioid epidemic -- has fallen off the front page, even as the damage and death it’s bringing to our country grows. In the 12 months ending in May 2020, the Centers for Disease Control and Prevention recorded more than 81,000 overdose deaths -- the most ever recorded in a 12-month period by the Centers.

• Read more about Accelerating Healthcare: Drug Diversion Surveillance

Five Questions Every Pharmacy Manager Should Ask About Physical Inventory

Pharmacy physical inventory is a critical but sometimes disruptive process within the healthcare system. But getting an accurate on-hand product count doesn’t have to interfere with everyday pharmacy operations. By engaging proven experts and asking the right questions, pharmacy managers can identify the best options available for driving improved inventory efficiency in support of greater profitability. So, here are five questions that pharmacy managers should ask to make sure they’re getting the professional inventory services they need -- and should expect. 

• Read more about Five Questions Every Pharmacy Manager Should Ask About Physical Inventory

INMAR INTELLIGENCE HOSTED DRUG DISPOSAL DRIVE-THRU EVENT AT WINSTON-SALEM HEADQUARTERS

Inmar Intelligence, in support of the DEA’s most recent National Prescription Drug Take-Back Day, hosted a consumer drug take-back event on October 24 at its Team Support Center in the Winston-Salem Innovation Quarter.  The drive-thru drug drop off was a collaboration between Inmar, the DEA, the State Bureau of Investigation and the Winston-Salem Police Department, enabling members of the community to safely and conveniently remain in their vehicles while disposing of unneeded medications.

• Read more about INMAR INTELLIGENCE HOSTED DRUG DISPOSAL DRIVE-THRU EVENT AT WINSTON-SALEM HEADQUARTERS

The Business of Pharmacy

The United States spends almost twice as much per capita on healthcare versus other developed countries. This level of expenditure is driving disruption -- which is occurring on many fronts, including reformation of retail pharmacy models. While COVID-19 created a catalyst for change, and clearly demonstrated the importance that retail pharmacies play in the healthcare ecosystem, the long-term viability of traditional models continues to be challenged.

• Read more about The Business of Pharmacy

2020 DSCSA Regulatory Update Verification for Pharmacies and Wholesalers

In light of the disruption brought to the pharmaceutical industry by the COVID-19 pandemic, the FDA recently issued updated guidance regarding its enforcement of key DSCSA verification requirements. As a service to the industry, Dwight de Vera, our General Manager, Healthcare Intelligence Solutions, provides a brief but insightful analysis of the FDA’s latest action in the video below.

• Read more about 2020 DSCSA Regulatory Update Verification for Pharmacies and Wholesalers